Screening and molecular characterization of Serratia marcescens VITSD2: A strain producing optimum serratiopeptidase

Abstract

The current work was attempted to isolate and characterize the serratiopeptidase producing Serratia sp. Among the 10 bacterial isolates 7 strains were identified as Serratia sp. Out of 7 strains one showed potent proteolytic activity and selected for further studies. Based on the morphological, biochemical and molecular characterization, the potent isolate (RH03) was identified as Serratia marcescens (GenBank accession number: KC961637) and the strain was designated as Serratia marcescens VITSD2. The production of serratiopeptidase was carried out in trypticase soya broth and the enzyme was partially purified using ammonium sulfate precipitation and dialysis. The specific activity was determined by casein hydrolysis assay and was found to be 12.00, 21.33, and 25.40 units/mg for crude, precipitated and dialysed samples. The molecular weight of the protease was determined by SDS-PAGE and it was found to be 50 kDa. The antibacterial activity of the produced serratiopeptidase showed moderate activity against Pseudomonas aeruginosa MTCC No. 4676 (12 mm) and Escherichia coli MTCC No. 1588 (15 mm).

Key words： Serratiopeptidase; Serratia marcescens VITSD2; antibacterial activity

Acknowledegment

We are greatly indebted to Vellore Institute of Technology for the constant encouragement, help and support for extending necessary facilities.

Conflict of interest

Subathra, Renuka, Harini, Jemimah and Mohanasrinivasan declare that they have no conflict of interest.

This article does not contain any studies with human or animal subjects performed by the any of the authors.

References

1 Aiyappa P S, Harris J O (1976). The extracellular metalloprotease of Serratia marcescens: I. Purification and characterization. Mol Cell Biochem, 13(2): 95–100

PMID

2 Altschul S F, Gish W, Miller W, Myers E W, Lipman D J (1990). Basic local alignment search tool. J Mol Biol, 215(3): 403–410

PMID

3 Chenna R, Sugawara H, Koike T, Lopez R, Gibson T J, Higgins D G, Thompson J D (2003). Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res, 31(13): 3497–3500

PMID

4 Decedue C J, Broussard E A N 2nd, Larson A D, Braymer H D (1979). Purification and characterization of the extracellular proteinase of Serratia marcescens. Biochim Biophys Acta, 569(2): 293–301

PMID

5 Ding Y, Lawrence C E (2003). A statistical sampling algorithm for RNA secondary structure prediction. Nucleic Acids Res, 31(24): 7280–7301

PMID

6 Felsenstein J (1985). Confidence limits on phylogenies: An approach using the bootstrap. Evolution, 39(4): 783–791

7 Grimont P A D, Grimont F, Dulong de Rosnay H L C (1977). Characterization of Serratia marcescens, S. liquefaciens, S. plymuthica and S. marinoruba by electrophoresis of their proteinases. J Gen Microbiol, 99(2): 301–310

8 Gruber A R, Lorenz R, Bernhart S H, Neuböck R, Hofacker I L (2008). The Vienna RNA websuite. Nucleic Acids Res, 36 (Web Server issue): W70-74.

PMID

9 Mohankumar A, Raj R H K, (2011). Production and characterization of Serratiopeptidase enzyme from Serratia marcescens. Int J Biol,3(3)

10 Holt J G (1994). Group 17 Gram-Positive Cocci: Bergey's Manual of Determinative Bacteriology, ed 9th. Baltimore: William & Wilkins: 529–541

11 Lowry O H, Rosebrough N J, Farr A L, Randall R J (1951). Protein measurement with the Folin phenol reagent. J Biol Chem, 193(1): 265–275

PMID

12 Machielsen R, Uria A R, Kengen S W M, van der Oost J (2006). Production and characterization of a thermostable alcohol dehydrogenase that belongs to the aldo-keto reductase superfamily. Appl Environ Microbiol, 72(1): 233–238

PMID

13 McCaskill J S (1990). The equilibrium partition function and base pair binding probabilities for RNA secondary structure. Biopolymers, 29(6-7): 1105–1119

PMID

14 Miguel F, Carrascosa José R (2013). Serratia marcescens rhabdomyolysis. Adv Inf Diseases, 3(02): 63–64

15 Miyata K, Maejima K, Tomoda K, Isono M (1970). Serratia protease.Part I.Purification and general properties of the enzyme. Agric Biol Chem, 34(2): 310–318

16 Nakahama K, Yoshimura K, Marumoto R, Kikuchi M, Lee I S, Hase T, Matsubara H (1986). Cloning and sequencing of Serratia protease gene. Nucleic Acids Res, 14(14): 5843–5855

PMID

17 Nirale N M, Menon M D (2010). Topical formulations of serratiopeptidase: development and pharmacodynamic evaluation. Indian J Pharm Sci, 72(1): 65–71

PMID

18 Saitou N, Nei M (1987). The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol, 4(4): 406–425

PMID

19 Subbaiya R, Ayyappadasan G, Mythili S V, Dhivya E, Ponmurugan P (2011). Pilot scale microbial production and optimization of Serratia peptidase from Serratia marcescens. J Ecobiotechnol, 3(12): 10–13

20 Trumbore MW, Rariy RV, Hirsh M, Hirsh J, Saunders JA(2005). Composition for topical enzymatic debridement. Collegium Pharmaceuticals, Inc, USPT application no. 20050281806–A1

21 Valeria M D, Borin M F, Fonseca M J (2003). Topical formulation with superoxide dismutase: Influence of formulation composition on physical stability and enzymatic activity. J Pharm Biomed Anal, 3(32): 97–105

22 Weissmann G (2006). Homeopathy: Holmes, Hogwarts, and the Prince of Wales. FASEB J, 20(11): 1755–1758

PMID

23 Yourassowsky E, van der Linden M P, Lismont M J, Crokaert F (1989). Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations. J Chemother, 1(Suppl 2): 49–53

PMID

24 Zuker M, Stiegler P (1981). Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res, 9(1): 133–148

PMID